NORGES BANK - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 111 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$511,000
-23.5%
51,1610.0%0.00%
Q3 2021$668,000
-33.3%
51,1610.0%0.00%
Q2 2021$1,002,000
-27.7%
51,161
-21.4%
0.00%
Q1 2021$1,385,000
-70.8%
65,108
-59.2%
0.00%
-100.0%
Q4 2020$4,740,000
+37.2%
159,4280.0%0.00%0.0%
Q3 2020$3,455,000
-32.7%
159,428
-30.7%
0.00%0.0%
Q2 2020$5,133,000
+46.5%
230,1950.0%0.00%0.0%
Q1 2020$3,504,000
-33.7%
230,1950.0%0.00%0.0%
Q4 2019$5,285,000
+463.4%
230,195
+667.3%
0.00%
Q2 2018$938,000
-5.7%
30,000
-40.0%
0.00%
Q1 2018$995,000
-31.5%
50,0000.0%0.00%
-100.0%
Q4 2017$1,453,00050,0000.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders